Vaxart Correlations
VXRT Stock | USD 0.34 0.01 2.86% |
The current 90-days correlation between Vaxart Inc and Inovio Pharmaceuticals is 0.18 (i.e., Average diversification). The correlation of Vaxart is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Vaxart Correlation With Market
Average diversification
The correlation between Vaxart Inc and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vaxart Inc and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Vaxart Stock
Moving against Vaxart Stock
0.7 | VALN | Valneva SE ADR | PairCorr |
0.67 | DRUG | Bright Minds Biosciences | PairCorr |
0.53 | VCYT | Veracyte | PairCorr |
0.51 | CMB | Cambium Bio | PairCorr |
0.51 | DMAC | DiaMedica Therapeutics | PairCorr |
0.5 | EQ | Equillium | PairCorr |
0.45 | RAC | Race Oncology | PairCorr |
0.35 | VERA | Vera Therapeutics | PairCorr |
0.33 | DNLI | Denali Therapeutics | PairCorr |
0.31 | DNTH | Dianthus Therapeutics | PairCorr |
0.53 | DSGN | Design Therapeutics | PairCorr |
0.47 | DTIL | Precision BioSciences | PairCorr |
0.41 | DWTX | Dogwood Therapeutics, | PairCorr |
0.39 | DRTS | Alpha Tau Medical | PairCorr |
0.61 | VTGN | VistaGen Therapeutics | PairCorr |
0.55 | VRDN | Viridian Therapeutics | PairCorr |
0.55 | VSTM | Verastem | PairCorr |
0.54 | BSFA | BSF Enterprise Plc | PairCorr |
0.49 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.37 | MRVL | Marvel Biosciences Corp | PairCorr |
Related Correlations Analysis
Risk-Adjusted Indicators
There is a big difference between Vaxart Stock performing well and Vaxart Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vaxart's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
INO | 3.52 | 0.92 | 0.26 | 0.53 | 3.02 | 8.44 | 30.78 | |||
IBIO | 3.28 | 0.00 | 0.02 | 0.05 | 3.27 | 7.59 | 35.13 | |||
CODX | 5.34 | 1.16 | 0.12 | 2.03 | 6.46 | 10.26 | 117.23 | |||
NVAX | 3.10 | 0.31 | 0.10 | 0.17 | 3.55 | 8.59 | 28.53 | |||
OCGN | 3.36 | 0.54 | 0.15 | 0.40 | 2.96 | 12.41 | 26.74 |
Vaxart Corporate Management
Sarah Khan | VP Resources | Profile | |
Rajesh Kapoor | Senior Quality | Profile | |
Shaily Garg | Senior Management | Profile | |
Brant Biehn | Sr Operations | Profile | |
Cezar MBA | Pres CEO | Profile |